- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04039425
Effects of Chemotherapy on the Concentration of Minerals in Hair
April 27, 2020 updated by: Edward Bitok, Loma Linda University
The purpose of the investigator's graduate student research study is to investigate if there are significant changes in hair mineral levels in cancer patients undergoing chemotherapy.
Study Overview
Detailed Description
Visit 1 - Before the start of chemotherapy
- Complete a questionnaire about demographics, health, and diet.
- Weight and height will be measured.
- A small sample of the participant's hair will be collected from the back side of the head near the base of the neck. Only the hair in the first inch closest to the scalp will be included in the sample. This hair sample will weigh 0.25g to 1g, which is about the same weight as one to two regular paper clips.
- The participant will be given a food frequency questionnaire
Visit 2- Approximately 2 months after start of chemotherapy
- The participant will complete a questionnaire about their health and diet.
- weight and height will be measured
- A small sample of the participant's hair will be collected from the back side of the head near the base of the neck. Only the hair in the first inch closest to the scalp will be included in the sample. This hair sample will weigh 0.25g to 1g, which is about the same weight as one to two regular paper clips.
- The participant will be given a food frequency questionnaire.
Study Type
Observational
Enrollment (Actual)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Loma Linda, California, United States, 92350
- Loma Linda University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects diagnosed with any type of cancer, Stages 1, 2 or 3, assigned to receive immunosupressive chemotherapy treatment.
Description
Inclusion Criteria:
- Are 18 years and older
- Recently diagnosed cancer stage 1, 2, or 3
- Assigned to receive immunosuppressive chemotherapy treatment
- Natural hair that has not been dyed or permed in the past 3 months
Exclusion Criteria:
• Prior chemotherapy treatment for cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cancer patient
|
Use only head hair.
Cut samples of hair from back of head (see illustration).
Cut hair as close to the scalp as possible.
As each piece of hair is cut from the head, save only 3.7 square inches of hair closest to the scalp.
According to the Doctors Data Lab, this amount is about enough hair to fill a tablespoon.
Cut off and discard the rest.
Place the saved hair on the scale.
Keep cutting and adding hair to the scale until it tips.
Hair collection will be about the weight of one to two paper clips (about 3800 strands).
Remove the hair on the scale and put it in the plastic bag.
Label the plastic bag with the patient's unique random identification and the date collected.
Put the hair into the plastic bag, seal, and send to The Doctor's Data Lab.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hair mineral levels(ug/g)
Time Frame: change between visit 1(baseline/start of chemotherapy) and visit 2 (about 2 months after visit 1)
|
Mineral levels such as calcium, magnesium, manganese, lead, iron, copper, cobalt, and chromium will be tested.
All mineral levels are in ug/g.
|
change between visit 1(baseline/start of chemotherapy) and visit 2 (about 2 months after visit 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edward Bitok, DrPH, Loma Linda University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2019
Primary Completion (Actual)
April 27, 2020
Study Completion (Actual)
April 27, 2020
Study Registration Dates
First Submitted
July 25, 2019
First Submitted That Met QC Criteria
July 29, 2019
First Posted (Actual)
July 31, 2019
Study Record Updates
Last Update Posted (Actual)
April 29, 2020
Last Update Submitted That Met QC Criteria
April 27, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 5190216
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Hair cut
-
Institut Cancerologie de l'OuestANSESCompletedSocioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children (PESTIFOL)Healthy Volunteer ChildrenFrance
-
Ankara City Hospital BilkentGeotek Medical Products Industry and Trade Co., Ltd., Ankara, TürkiyeCompleted
-
Superior UniversityActive, not recruiting
-
General University Hospital, PragueRecruiting
-
Bangladesh Agricultural UniversityCompletedGastrointestinal Diseases | Foodborne Diseases | Escherichia Coli | Microbial Contamination | Street Vended Foods | S. Aureus | Total Viable CountBangladesh
-
Sohag UniversityNot yet recruiting
-
NovoBliss Research Pvt LtdCompleted
-
Nutraceutical Wellness Inc.CompletedHair ThinningUnited States
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingLocalized Scleroderma | Fat Grafting | Hair Transplantation